BIOMAT Database Logo BIOMAT Database Logo

High-performance liquid chromatographic analysis of plasma levels of nalbuphine in cardiac surgical patients. 1982

C L Lake, and C A DiFazio, and E N Duckworth, and J C Moscicki, and J S Engle, and C G Durbin

UI MeSH Term Description Entries
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009019 Morphinans Compounds based on a partially saturated iminoethanophenanthrene, which can be described as ethylimino-bridged benzo-decahydronaphthalenes. They include some of the OPIOIDS found in PAPAVER that are used as ANALGESICS. Morphinan
D009266 Nalbuphine A narcotic used as a pain medication. It appears to be an agonist at KAPPA RECEPTORS and an antagonist or partial agonist at MU RECEPTORS. EN-2234A,Nalbuphine Hydrochloride,Nalbuphine Serb,Nubain,EN 2234A,EN2234A
D009270 Naloxone A specific opiate antagonist that has no agonist activity. It is a competitive antagonist at mu, delta, and kappa opioid receptors. MRZ 2593-Br,MRZ-2593,Nalone,Naloxon Curamed,Naloxon-Ratiopharm,Naloxone Abello,Naloxone Hydrobromide,Naloxone Hydrochloride,Naloxone Hydrochloride Dihydride,Naloxone Hydrochloride, (5 beta,9 alpha,13 alpha,14 alpha)-Isomer,Naloxone, (5 beta,9 alpha,13 alpha,14 alpha)-Isomer,Narcan,Narcanti,Abello, Naloxone,Curamed, Naloxon,Dihydride, Naloxone Hydrochloride,Hydrobromide, Naloxone,Hydrochloride Dihydride, Naloxone,Hydrochloride, Naloxone,MRZ 2593,MRZ 2593 Br,MRZ 2593Br,MRZ2593,Naloxon Ratiopharm
D012015 Reference Standards A basis of value established for the measure of quantity, weight, extent or quality, e.g. weight standards, standard solutions, methods, techniques, and procedures used in diagnosis and therapy. Standard Preparations,Standards, Reference,Preparations, Standard,Standardization,Standards,Preparation, Standard,Reference Standard,Standard Preparation,Standard, Reference
D002851 Chromatography, High Pressure Liquid Liquid chromatographic techniques which feature high inlet pressures, high sensitivity, and high speed. Chromatography, High Performance Liquid,Chromatography, High Speed Liquid,Chromatography, Liquid, High Pressure,HPLC,High Performance Liquid Chromatography,High-Performance Liquid Chromatography,UPLC,Ultra Performance Liquid Chromatography,Chromatography, High-Performance Liquid,High-Performance Liquid Chromatographies,Liquid Chromatography, High-Performance
D004563 Electrochemistry The study of chemical changes resulting from electrical action and electrical activity resulting from chemical changes. Electrochemistries
D006207 Half-Life The time it takes for a substance (drug, radioactive nuclide, or other) to lose half of its pharmacologic, physiologic, or radiologic activity. Halflife,Half Life,Half-Lifes,Halflifes
D006349 Heart Valve Diseases Pathological conditions involving any of the various HEART VALVES and the associated structures (PAPILLARY MUSCLES and CHORDAE TENDINEAE). Heart Valvular Disease,Valvular Heart Diseases,Disease, Heart Valvular,Heart Disease, Valvular,Heart Valve Disease,Heart Valvular Diseases,Valve Disease, Heart,Valvular Disease, Heart,Valvular Heart Disease
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

C L Lake, and C A DiFazio, and E N Duckworth, and J C Moscicki, and J S Engle, and C G Durbin
Detection of nalbuphine in plasma: an improved high-performance liquid chromatographic assay.
November 1984, Journal of chromatography,
C L Lake, and C A DiFazio, and E N Duckworth, and J C Moscicki, and J S Engle, and C G Durbin
Rapid and sensitive high-performance liquid chromatographic assay for nalbuphine in plasma.
January 1995, Journal of chromatography. B, Biomedical applications,
C L Lake, and C A DiFazio, and E N Duckworth, and J C Moscicki, and J S Engle, and C G Durbin
High-performance liquid chromatographic analysis of captopril in plasma.
June 1981, Journal of pharmaceutical sciences,
C L Lake, and C A DiFazio, and E N Duckworth, and J C Moscicki, and J S Engle, and C G Durbin
High-performance liquid chromatographic analysis of iodochlorhydroxyquin in plasma.
August 1981, Journal of pharmaceutical sciences,
C L Lake, and C A DiFazio, and E N Duckworth, and J C Moscicki, and J S Engle, and C G Durbin
High-performance liquid chromatographic analysis of miconazole in plasma.
January 1982, Journal of chromatography,
C L Lake, and C A DiFazio, and E N Duckworth, and J C Moscicki, and J S Engle, and C G Durbin
High-Performance Liquid-Chromatographic Analysis of Plasma Iohexol Concentrations.
October 2015, Journal of chromatographic science,
C L Lake, and C A DiFazio, and E N Duckworth, and J C Moscicki, and J S Engle, and C G Durbin
Stereospecific high-performance liquid chromatographic analysis of warfarin in plasma.
August 1983, Journal of pharmaceutical sciences,
C L Lake, and C A DiFazio, and E N Duckworth, and J C Moscicki, and J S Engle, and C G Durbin
High-performance liquid chromatographic analysis of hypoxanthine arabinoside in plasma.
May 1984, Journal of chromatography,
C L Lake, and C A DiFazio, and E N Duckworth, and J C Moscicki, and J S Engle, and C G Durbin
High-performance liquid chromatographic analysis of 5-fluorouracil in plasma.
April 1978, Journal of chromatography,
C L Lake, and C A DiFazio, and E N Duckworth, and J C Moscicki, and J S Engle, and C G Durbin
High-performance liquid chromatographic analysis of amodiaquine in human plasma.
January 1985, Journal of chromatography,
Copied contents to your clipboard!